东方盛虹(000301.SZ):控股股东及其关联企业的部分员工拟增持公司5亿-8.45亿元股份
格隆汇3月23日丨东方盛虹(000301.SZ)公布,公司于2020年3月23日接到公司控股股东江苏盛虹科技股份有限公司(“盛虹科技”)的通知,盛虹科技及其关联企业(除上市公司及上市公司控股子公司外)的部分员工拟委托金融机构成立专项集合资金信托计划(“集合资金信托”)通过二级市场购买等方式增持公司股份。
此次增持拟由盛虹科技或其关联企业选定的金融机构专项设立集合资金信托,预计总规模在5亿元至8.45亿元之间,拟持有上市公司股票总数累计不超过上市公司股本总额的5%;单个员工所获股份权益对应的股票总数累计不超过上市公司股本总额的1%。具体认购规模将根据参与者的认购情况而定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.